会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Inhibition of &bgr;-amyloid binding to the p75 nerve growth factor receptor
    • 抑制β-淀粉样蛋白结合p75神经生长因子受体
    • US06242416B1
    • 2001-06-05
    • US09163095
    • 1998-09-29
    • Barbara A. GilchrestMina Yaar
    • Barbara A. GilchrestMina Yaar
    • A61K3800
    • C07K5/0815A61K38/00C07K14/4711C07K14/48G01N33/6896G01N2333/4709G01N2800/2821
    • Methods of inhibiting &bgr;-amyloid-mediated activation of the p75 nerve growth factor receptor of a cell that expresses the p75 nerve growth factor receptor are provided. Methods of inhibiting the binding of &bgr;-amyloid protein and &bgr;-amyloid peptides to the p75 nerve growth factor receptor, and methods of inhibiting &bgr;-amyloid-mediated apoptosis of neural crest-derived cells are provided. The methods comprise contacting the cell with a substance, comprising, for example, the amino acid sequence lysine-glycine-lysine (KGK) or lysine-glycine-alanine (KGA), wherein the substance binds to the p75 nerve growth factor receptor, resulting in the inhibition of &bgr;-amyloid protein or &bgr;-amyloid peptide binding to and/or activation of the p75 nerve growth factor receptor, or wherein the substance inhibits &bgr;-amyloid protein or &bgr;-amyloid peptide mediated apoptosis of the cell which expresses the p75 nerve growth factor receptor.
    • 提供了抑制β-淀粉样蛋白介导的表达p75神经生长因子受体的细胞的p75神经生长因子受体活化的方法。 提供了抑制β-淀粉样蛋白和β-淀粉样肽与p75神经生长因子受体结合的方法,以及抑制β-淀粉样蛋白介导的神经嵴衍生细胞凋亡的方法。 所述方法包括使细胞与包含例如氨基酸序列赖氨酸 - 甘氨酸 - 赖氨酸(KGK)或赖氨酸 - 甘氨酸 - 丙氨酸(KGA)的物质接触,其中所述物质与p75神经生长因子受体结合,得到 在β-淀粉样蛋白或β-淀粉样肽与p75神经生长因子受体结合和/或活化的抑制中,或其中该物质抑制β-淀粉样蛋白或β-淀粉样肽介导的表达p75的细胞的凋亡 神经生长因子受体。
    • 9. 发明授权
    • Use of locally applied DNA fragments
    • 使用局部应用的DNA片段
    • US5955059A
    • 1999-09-21
    • US467012
    • 1995-06-06
    • Barbara A. GilchrestMark EllerMina Yaar
    • Barbara A. GilchrestMark EllerMina Yaar
    • C07H21/04A01N43/04A61K9/08A61K9/12A61K9/127A61K31/70A61K47/10A61P17/00A61P17/02A61P17/06A61P17/16A61P35/00C12N15/00A61K7/42
    • A61K31/7048A61K31/711
    • Methods of treatment or prevention of hyperproliferative diseases or pre-cancerous conditions affecting epithelial cells, such as psoriasis, vitiligo, atopic dermatitis, or hyperproliferative or UV-induced dermatoses, and methods for reducing photoaging or for prophylaxis against or reduction in the likelihood of the development of skin cancer, are disclosed. The methods comprise administering to the cells of interest an effective amount of DNA fragments, either single- or double-stranded, or a mixture of both single- and double-stranded fragments, or deoxynucleotides, dinucleotides, or dinucleotide dimers. The DNA fragments, deoxynucleotides, dinucleotides, or dinucleotide dimers can be administered in an appropriate vehicle, such as a liposomal preparation or propylene glycol. Preparations useful in the present methods are additionally disclosed. The preparations comprise DNA fragments, either single- or double-stranded, or a mixture of both single- and double-stranded fragments, or deoxynucleotides, dinucleotides, or dinucleotide dimers, and an appropriate delivery vehicle, such as liposomes or propylene glycol.
    • 治疗或预防影响上皮细胞如银屑病,白癜风,特应性皮炎或过度增生性或UV诱导的皮肤病的过度增殖性疾病或癌前病症的方法,以及用于减少光老化或预防或降低可能性的方法 公开了皮肤癌的发展。 所述方法包括向感兴趣的细胞施用有效量的单链或双链的DNA片段,或单链和双链片段或脱氧核苷酸,二核苷酸或二核苷酸二聚体的混合物。 DNA片段,脱氧核苷酸,二核苷酸或二核苷酸二聚体可以在合适的载体如脂质体制剂或丙二醇中施用。 另外公开了本发明方法中有用的制剂。 制备物包括单链或双链的DNA片段,或单链和双链片段或脱氧核苷酸,二核苷酸或二核苷酸二聚体以及合适的递送载体如脂质体或丙二醇的混合物。